NURIX THERAPEUTICS, INC. (NRIX)

SEC filing

NURIX THERAPEUTICS, INC.

NRIX · CIK 1549595

4 · Oct 15, 2026 · Chief Scientific Officer Hansen Gwenn sold 1,452 shares at $25.00/share ($36,300); exercised options for 2,904 shares

Chief Scientific Officer Hansen Gwenn sold 1,452 shares at $25.00/share ($36,300); exercised options for 2,904 shares

FORM 4

xslF345X06/wk-form4_1792098025.xmlSEC.gov

Graphics and non-inline formats (not embedded below).